Related by context. All words. (Click for frequent words.) 62 please visit http:/www.weingarten.com 57 PharMerica LTC Transaction 57 looking statementsaEUR describe 57 Zemiva TM 57 Thalomid R 57 Surfaxin LS 56 please visit www.middlebrookpharma.com 56 productdevelopment 56 technological innovations adversely affecting 56 BLA filing 56 ZaBeCor 56 Allovectin 7 r 56 initiate Phase IIb 55 Eligard ® 55 prioritization Shindo 55 commercialize BiDil 55 APTIMA HPV assay 54 commercialize ZYFLO CR 54 Inc NGSX 54 HepeX B 54 immunotherapies 2A/Furin 54 Rexahn licensees 54 Thelin tm 54 DPX Survivac 54 Doral ® quazepam 54 RECOTHROM ® 54 BioGlue ® 54 Synagis palivizumab 54 SinuNase ™ 54 regarding AngelCiti 54 Loramyc TM 54 BiDil XR 54 Lexiscan ® 54 BioSante licensees 54 AzaSite TM 54 BC SeraPro proteomic 54 successfully commercialize Iluvien 53 apricitabine ATC 53 Zemiva TM Trofex TM 53 divest noncore assets 53 Alnylam #x# 53 novel L DOS# 53 PLAVIX ® 53 MethyPatch 53 statements arebased 53 vaginal lidocaine 53 developing calcitonin 53 RAPTIVA R 53 develop electroporation 53 repopulate CNS 53 newproducts 53 molecular chaperone regulation 53 Neo Kidney Augment 53 develop viable ZENNergy 53 Pfizer inhaled insulin 53 Nektar pulmonary 53 Asentar TM 53 notlimited 53 antibacterial therapeutics 53 P#X# antagonist 53 visit www.targanta.com 53 RXi Pharmaceutical Corporation 52 includingstatements regarding 52 iii Cubist 52 Publication Classified Ad 52 risksassociated 52 oncolytic virus therapies 52 candidate CRLX# 52 Insegia 52 RIGScan CR 52 LA GO GO 52 visit http:/www.cytrx.com 52 GVAX cancer 52 please visit www.cpexpharm.com 52 toimplement 52 visit www.sciclone.com 52 Tyzeka Sebivo 52 STRIANT ® 52 Eligard R 52 sumatriptan DosePro 52 Arcadia HealthCare comprehensive 52 AcryMed Incorporated 52 research anddevelopment 52 MEDAREX 52 Plenaxis R 52 subsidiaries visit http:/www.apricusbio.com 52 Firazyr ® 52 Stimuvax R 52 www.weingarten.com 52 Zeneus 52 domestic andinternational 51 vaginally administered lidocaine 51 5 lipoxygenase inhibitor 51 M Enoxaparin 51 Mr. Karbe 51 ADSI reliance 51 ZEGERID ® 51 proprietary MSCRAMM protein 51 reflect Ronn Motor 51 strategy GlobalData summarization 51 NASDAQ GNTA 51 commercialize axon regeneration 51 OLEPTRO 51 MDx tests 51 unique PER.C6 ® 51 Newtek beliefs 51 operates Windstar Cruises 51 Thoma Bravo applies 51 Bioaccelerate compounds under 51 sNDAs 51 PD2i Analyzer TM 51 PER.C6 ® production 51 strategy summarization 51 please visit www.palmharbor.com 51 MGI PHARMA marketed 51 Kiadis 51 Kosan dependence 51 ourproducts 51 INTEGRILIN R eptifibatide Injection 51 rheumatoid arthritis thrombocytopenia 51 commercializing Loramyc ® 51 Zavesca r 51 proprietary intranasal insulin 51 gallium nitrate injection 51 therapeutic anticancer 51 Plasma Converter TM 51 statementsregarding 51 MTI MTI Micro 51 ESTRASORB ® 51 tablet purgative preparation 51 Glucose RapidSpray TM 51 inflammatory autoimmune diseases 51 JV SpeBio 51 HuMax TAC 51 Hematide ™ peginesatide 51 JM Dutton adds 51 Mr. Jinsheng Ren 51 initiate multicenter 51 gepirone ER 51 NeutroTest TM 51 NASDAQ GPCB today 51 Panzem ® 51 Lovaza TM 51 vii IBC 51 Acticoat TM products 50 visit http:/www.chinawindsystems.com 50 Goodbody Stockbrokers adds 50 Retains CCG Investor Relations 50 visit www.adm.com 50 Nanobody R 50 InterfeRx TM 50 Inc NASDAQ CISG 50 HCV protease inhibitors 50 cadence regulatory approvals 50 proprietary capillary aerosolization 50 commercialize NicVAX 50 ESTRASORB R 50 Bacterin develops manufactures 50 TransVax ™ 50 molecular diagnostic kits 50 CEFF financings subject 50 KRYSTEXXA ™ 50 Promus Element stent 50 TOCOSOL Paclitaxel 50 proprietary bioresorbable polymer 50 commented Alexis Borisy 50 Inc CRIS 50 IFRS changeover 50 TriActiv 50 CORLUX CORT # 50 AnGes MG Inc. 50 ability tosuccessfully 50 Other ImmunoGen collaborative 50 ALN RSV program 50 stated Dominique Costantini 50 naronapride 50 website http:/www.celsion.com 50 Benlysta belimumab 50 Zyprexa Cymbalta 50 CoTherix logo 50 Alnylam RNAi 50 faropenem medoxomil 50 Evoltra ® 50 Immunology Urology Anti Infectives 50 www.clenergen.com 50 CRMD# 50 LEVADEX ™ 50 Preotact ® 50 Immtech clinical trials 50 Rami Efrati CEO 50 CIP TRAMADOL ER 50 budesonide MMX Phase III 50 breast cancer pill Tykerb 50 Nicotine Conjugate Vaccine 50 Amends Stockholder Rights 50 IoGen ™ 50 Solasia 50 topical agent Xantryl 50 EGRIFTA TM 50 Prelude SkinPrep Systems 50 should consult NeurogesX 50 RGRX 50 copromotion 49 Alnylam dependence 49 Dyax logo 49 Protexia ® 49 incorporating FalconStor 49 Ecoval 49 carbonate Direct FuelCell 49 XenoPort dependence 49 describe CoBiz 49 leading lipid nanoparticle 49 oral taxane 49 inception POZEN 49 Thalomid ® 49 signal averaging electrocardiography 49 ZENNergy TM drivetrain 49 Generx TM 49 NV Organon 49 jettison unprofitable 49 Dr. Scangos 49 subsidiary Scient'x SA 49 Convera filings 49 nucleoside tide 49 CAUTIONARY STATEMENT Estimates 49 Shigamabs R 49 generic Copaxone 49 GELV gasification technology 49 FirstMortgage mortgage origination 49 purinergic receptors P#X# 49 products andservices 49 OraTest R 49 Roche Trimeris 49 Kroger Outback Steakhouse 49 Nasdaq PARD biopharmaceutical 49 Canvaxin TM 49 pulls Darvon painkiller 49 7ACA 49 Caleco Pharma 49 ResponseDX ™ tests 49 Project Boveri Find 49 GlaxoSmithKline Plc AstraZeneca Plc 49 inlicensing 49 OraTest 49 subsidiary ReceptoPharm 49 programs visit http:/www.dendreon.com/ 49 recombinant biopharmaceutical 49 ReCyte 49 assimilating acquired 49 zileuton IV 49 Qutenza ® 49 AcryMed technologies 49 tools meganucleases 49 products visit www.adm.com 49 Acetavance TM intravenous acetaminophen 49 Tibotec BVBA 49 Inc XNPT 49 ELEVESS 49 PER.C6 r 49 SILENOR 49 Honeywell Blackboard 49 STRIANT R 49 unique PER.C6 49 NES Clothing 49 balance sheet deleveraging 49 submit Biologics License 49 Corporation GENZ GENZ 49 Teveten 49 VIBATIV ™ 49 XP# XP# 49 Intraject R 49 website www.celsion.com 49 Healive TM 49 PANVAC VF 48 deforolimus 48 Cephalon GlaxoSmithKline Organon 48 Bionutrics 48 risks anduncertainties 48 arenot limited 48 Heska reliance 48 Alprox TD 48 commercializing ophthalmic 48 POSIDUR TM 48 TRIOLE R 48 Alnylam Biotherapeutics 48 Sepracor anticipates 48 outlicensing 48 torsemide ER 48 myasthenia gravis Huntington 48 Celacade TM System 48 Boehringer Ingelheim MedImmune 48 MEDA AB publ 48 Hoji Alimi founder 48 Approves Stock Repurchase 48 proprietary transdermal 48 visit www.dendreon.com 48 TAPET R 48 Aceon 48 EMPOWER pivotal trial 48 polymeric formulations 48 LO LOESTRIN FE 48 systemic immunosuppressive drugs 48 transmucosal delivery system 48 Reports Inducement Grants 48 Hedgehog antagonist 48 Caliper Driven 48 Adopts Stockholder Rights 48 Phase lll 48 CRHI 48 SANCTURA R 48 systemic RNAi 48 Phase III LibiGel 48 Nascobal 48 CSLR expectations regarding 48 ProPhotonix 48 Chimigen TM 48 TP# CETi 1 48 MassARRAY platform 48 UltiMAb 48 cMET inhibitor 48 FalconStor OEM 48 visit www.mediasciences.com E 48 Advanced Engineered Materials 48 KRYSTEXXA TM pegloticase 48 visit corp.orbitz.com 48 TaiGen 48 forge strategic alliances 48 CLIRS trial 48 pathologists oncologists hospitals 48 Oxandrin ® 48 andfinancial 48 HCV antiviral 48 Pharmacia Diagnostics 48 withrespect 48 EGRIFTA 48 PGxPredict tests 48 NanoKnife IRE System 48 DepoVax ™ vaccine 48 Dyax phage display 48 novel antibody therapeutics 48 punctal plug delivery 48 IND submission 48 ASX UNS 48 novel anti infective 48 SPARLON 48 visit http:/www.dendreon.com 48 CCR9 antagonist 48 Staccato nicotine technology 48 patented CompuFlo R 48 GVAX R 48 Mexcor International 48 MassARRAY ® 48 Panbio Limited 48 glucokinase activator 48 ZEGERID R 48 PAION AG ISIN 48 Urocidin 48 vaccines oncolytic virus 48 MediGene focuses 48 Vaxfectin R adjuvant 48 ACCLAIM II 48 Captisol ® 48 Endotis 48 Inc. NASDAQ TRMP 48 Rosetta dependence 48 please visit www.comstockhomebuilding.com 48 successfully commercialize Silenor 48 using VIAdel TM 48 serious systemic Staphylococcal 48 Extendryl R 48 ZEVALIN ® 48 calcium phosphate nanotechnology CaP 48 candidate Trofex TM 48 novel therapeutic antibodies 48 develop PS# 48 AIMM trial 48 regenerative therapeutics programs 48 SynCon 48 Allovectin 7 48 Tohoku Pioneer Corporation 48 Canvaxin 47 Toric ICL 47 arebased 47 Aganocide TM 47 totaled EUR#.#bn 47 Rozetta Cell 47 AdVac R 47 PVC additives 47 Ascension Orthopedics sells 47 LentiVector technology 47 ZURICH AFX Novartis AG 47 XcelaSAN ® 47 please visit http:/www.chinaenergyrecovery.com/s/Mushahary 47 Ruconest ™ 47 risksand uncertainties 47 Zensana TM 47 ZFP Therapeutics 47 Fanapt ® 47 vii Cubist ability 47 Troxatyl 47 telomerase inhibitor drug 47 treat dysmenorrhea 47 companiesâ € ™ 47 visit www.bioject.com 47 ArQule Kinase Inhibitor Platform 47 punctal plug 47 topical dermatology 47 Shigamabs ® 47 IL# PE 47 noninvasive prenatal tests 47 Dr. Tsengas 47 mTCR 47 TrueKnowledge Platform TM 47 fund BioSante LibiGel 47 technology subsidiary TradeStation 47 microsurgical disciplines 47 intravenous AAT 47 Behcet uveitis 47 footwear apparel accessories 47 bafetinib demonstrated 47 Q1 Adj 47 Glucomed 47 HELSINN 47 Somatuline R Depot 47 regarding Heska 47 consummating acquisitions 47 oral NSAIDs 47 Approvable letter 47 candidate FavId 47 BC SeraPro 47 BIOTECH STOCKS Drug 47 Praecis 47 Biologic License Application BLA 47 Accutest R 47 cytoskeletal pharmacology 47 romazarit 47 Peer Schatz QIAGEN 47 visit www.exobox.com 47 prescription brands RESTYLANE 47 investigating pralatrexate 47 Lexiscan R 47 AzaSite Xtra 47 XL# anticancer compounds 47 squalamine 47 Multiplied Media announces 47 Nabi HB Intravenous 47 Bioenvision dependence 47 derivatives ADV 47 Sular ® 47 NxStage anticipates 47 Azedra TM Onalta TM 47 initiate Phase Ib 47 Martin Nicklasson 47 By DOUGLAS MCINTYRE 47 Auxilium anticipates 47 commercialize DAVANAT ® 47 wholly owned subsidiary Ecologix 47 gluteal injection 47 todevelop 47 Ofirmev 47 Quotestream II 47 AMPK activators 47 HepDirect R 47 Quaker BioVentures invests 47 prolific Slave Craton 47 please visit http:/www.globalaxcess.biz 47 AstraZeneca MedImmune 47 transdermal estradiol gel 47 Chaim Lebovits President 47 please visit www.ldksolar.com 47 Mr. Melnuk 47 Bioral Amphotericin B. 47 toreflect 47 Nycomed GmbH 47 Arcelis TM 47 Allegra D# 47 andmarket 47 ReN# stem cell 47 KL4 surfactant pipeline 47 targeted molecular radiotherapeutics 47 concerning CombinatoRx 47 e2 Collector 47 vii Dynamic 47 Vendor Managed Inventory VMI 47 Restate Financials 47 RecoveryRx 47 advance Debio 47 LFRP 47 EVIZON TM squalamine lactate 47 autologous cellular therapy 47 highly leveragable 47 Shigamabs 47 Enpath ability 47 VALOR trial 47 PINKSHEETS THRA 47 e mail lifestyle@readingeagle.com 47 Nektar proprietary 47 concerning Alnylam 47 LSE PFZ 47 Inc. NASDAQ SDTH 47 This exemplifies SYSPRO 47 immunotherapeutic approaches 47 Restanza TM 47 Igeneon AG 47 initiate Phase 1b 47 Mesafem 47 histamine dihydrochloride 47 Modelevi 47 evaluating intravenous picoplatin 47 INVOS System products 47 Enzo Therapeutics 47 DSD Dairy segment 47 Dr. Raafat Fahim 47 Intas Biopharmaceuticals 47 Daytrana TM 47 Atheros Quarterly Report 47 rPA vaccine candidate 46 mertansine 46 InterfeRx 46 proprietary VLP 46 cellular immunotherapy 46 Inaddition 46 resultsof 46 visit www.ethosfr.com 46 Evoclin 46 oral methylnaltrexone 46 Biodefense Division 46 VeraTag assays 46 Rhucin R 46 Nasdaq PGNX today 46 Amlodipine Besylate Tablets 46 Quinvaxem TM 46 maturation inhibition 46 molecular radiotherapeutics 46 Prochymal Chondrogen 46 oral salmon calcitonin 46 barrenwort extraction efficiency 46 implantable neurostimulation 46 Achieves Record Quarterly 46 SEASONIQUE 46 Vaxfectin ® 46 Strengthens Balance Sheet 46 hoFH 46 Bioaccelerate 46 SILCRYST TM coatings 46 Sankyo Pharma 46 Laboratoires Thea 46 risks associatedwith 46 delivers sumatriptan 46 SpeBio joint venture 46 Crisa acquisition 46 Teveten HCT 46 Announces License Agreement 46 oral Cold Remedy 46 combine recombinant protein 46 please visit www.metatroninc.com 46 initiate Phase IIa 46 BioFocus DPI Galapagos 46 peramivir clinical trials 46 intranasal insulin product 46 VUE Software 46 apply Enhanze technology 46 biotherapeutic drugs 46 subsidiary Kinergy Marketing 46 Orosi Mill project 46 Zenyaku Kogyo 46 ourability 46 MyVax ® 46 generic clopidogrel bisulfate 46 EOIR insufficient cash 46 VYVANSE TM lisdexamfetamine 46 Hedgehog agonist 46 Purifine ® PLC 46 Renewable Ventures Fotowatio 46 changesin 46 Ups Guidance 46 codeveloping 46 inhaled AAT 46 subsidiary Amyris Fuels 46 include ClindaReach TM 46 LibiGel ® Phase III 46 novel therapeutic modality 46 FLECTOR Patch 46 eprodisate KIACTA TM 46 opinions visit blog.radvision.com 46 Solvay pharma 46 orally disintegrating formulation 46 Sandoz generics unit 46 immuno therapeutic 46 including withoutlimitation 46 targeting abnormally proliferating 46 product Visicol R 46 synthetic retinoid 46 Announces Discontinuation 46 acyclovir Lauriad R 46 thebenefits 46 MAXY alpha 46 Enters Into Licensing Agreement 46 midstage trials 46 Rule Breakers selection 46 HuCAL technology 46 Generex Oral lyn tm 46 Camvia 46 theseforward looking 46 Theragenics TM 46 visit www.cytrx.com 46 cancer immunotherapies 46 x fluctuating beryllium 46 andconsumer 46 Harry Palmin President 46 About Biovitrum Biovitrum 46 toachieve 46 services visit www.nei.com 46 SAR# [004] 46 Patients administer LEVADEX 46 PD2i ® algorithm 46 Oncogenex 46 AeroLEF R 46 photodisinfection 46 Novartis NVS Snapshot Report 46 Bicifadine 46 Preclinical Platform 46 candidate Ramoplanin 46 PDE# inhibitors 46 Revises Guidance 46 buccal delivery 46 Les Crudele president 46 WILEX 46 AdhTAP 46 BioFX Laboratories 46 hematological indications 46 EGRIFTA ™ 46 Provecta 46 Maxy G# 46 transcatheter valve technologies 46 Inc. NASDAQ CVTX 46 deploy MDCE services 46 Lauriad 46 AGGRASTAT R tirofiban hydrochloride 46 Phase 2a clinical trials 46 neoprobe ® GDS 46 Jiangyin plant 46 Novartis Sanofi Aventis 46 CLX Investments 46 Formulate effective 46 Shire plc Attention Deficit 46 Urocortin 2 46 ATPT 46 ENABLE Phase 2 46 radioactive particles TEPCO 46 anticipations beliefs expectations 46 Takeda Kyowa Hakko Kirin 46 ICx develops 46 OTCBB PYTO 46 OLIGON technology 46 Sepracor patents 46 LibiGel NDA 46 Roch Doliveux CEO 46 EMPOWER TM 46 please visit www.advantex.com 46 ourbusiness 46 workflow toolsets 46 GVAX Immunotherapies 46 IoGen TM 46 Ultimate Squeegee 46 adversely affect Univest Corporation 46 OGE Enogex Partners LP 46 adjuvant GIST 46 vosaroxin 46 manufacture RISPERDAL CONSTA 46 Neurobionix 46 Prosaptide 46 treats acute lymphoblastic 45 Company Skouries Olympias 45 clinical trials dacetuzumab SGN 45 OTC ZEGERID 45 & TSX NBY 45 expressively disclaims 45 Ceragenin ™ technology 45 Adnectin 45 Domilens 45 SEASONALE 45 STOCRIN 45 filingswith 45 tizanidine hydrochloride short 45 NYSE FRX longstanding 45 cathepsin K inhibitor 45 RapidResponse TM DNA 45 acne impetigo 45 adrenergic regulation 45 Q#IR 45 www.ilgenetics.com 45 PROMACTA CARES 45 CMV vaccine 45 Ampakine compounds 45 SMA Indústria Química SA 45 estradiol transdermal spray 45 2A/Furin 45 Spiegelmer ® 45 targeted anticancer therapies 45 Orathecin 45 HEPLISAV TM hepatitis B 45 website www.nyandcompany.com 45 objectives therefor 45 Arpaio crackdowns 45 AB OMXS BINV 45 Announces Licensing Agreement 45 CEO Magnus Ryde 45 andsolutions 45 Exploit collaboration 45 Intas Biopharma 45 Puricase PEG uricase 45 commercialize StaphVAX 45 Chief Executive Hubertus Erlen 45 alvespimycin 45 Xylodyne 45 Somatuline R Autogel 45 EHT AGN 45 histrelin manufacturing marketing 45 darifenacin 45 initiate Phase 2b 45 HuCAL antibodies 45 dispositions joint ventures 45 tramiprosate Alzhemed TM 45 Xianling Gubao 45 ii Immtech ability 45 http:/www.ilgenetics.com 45 CytoFabTM 45 GoSolutions 45 EXACT Sciences technologies 45 Amylin Lilly 45 SANCTURA SANCTURA XR NEBIDO 45 thecompletion 45 PRESEPT study 45 protein biochip 45 neurodegenerative diseases oncology 45 topical anti infective 45 Quinvaxem R 45 Backs FY# Adj 45 xxiv import export 45 RIGScan 45 Adopts Shareholder Rights 45 MolecularBreeding 45 Prochieve R 45 XIENCE V drug eluting 45 Albany Molecular AMRI 45 Oscient promotes ANTARA 45 ThyroTest R 45 InvaGen 45 Including newbuildings 45 GLASSIA 45 FSRU conversions 45 initiated Phase Ib 45 underwriter WR Hambrecht 45 tomarket 45 therapeutic Nanobodies 45 Fibrosis Foundation Therapeutics 45 futureresults 45 AFFITOME R 45 immatics 45 rotary VAD 45 CRM Cegedim Dendrite 45 VanceInfo filings 45 PINKSHEETS PHMB 45 THR beta agonist 45 valopicitabine NM# 45 Dr. Stylli 45 drug Avinza 45 PharmFilm R 45 CVac 45 OrCrude TM process 45 Synergyn TM 45 ionotropic glutamate receptor antagonists 45 DepoMed 45 CRACM 45 LOMUCIN TM 45 Nasdaq SGEN 45 commercialize toremifene 45 OrthoCyte 45 EvoraPlus TM 45 RenalGuard System TM 45 PV module efficiencies 45 xi unanticipated 45 Nuance managements 45 DailyMed TM 45 Extends Collaboration 45 Smarter Sponge ™ 45 nextGEN 45 GenWay 45 Avian Transgenic Technology 45 confirmatory pivotal 45 PrevOnco ™ 45 Pictometry customizes 45 Cooled ThermoTherapy 45 By DAVID SCHEPP 45 GLASSIA ™ 45 VaxImmune 45 elotuzumab 45 Nasdaq OPTR 45 refranchising initiative 45 NovaCal 45 BioGeneriX 45 London AiM GLPG 45 EpiTherapeutics 45 offerings visit www.balqon.com 45 Zevtera 45 MSCRAMM 45 Samjin 45 GED aPC 45 vaccine Synflorix 45 Sanctura XR 45 Echo Symphony tCGM 45 Zelnorm Zelmac 45 Dowslake 45 Triapine R 45 molecular therapeutics immunotherapies 45 generic Flomax 45 phage display technology 45 OX2 engine 45 ongoing Phase IIIb 45 oral NKTR 45 IND Investigational New 45 anti infective treatments 45 therapeutic mAbs 45 adversely affect Waste Connections 45 Approves Stock Buyback 45 fungal infections malaria tuberculosis 45 opioid bowel dysfunction 45 Crexendo Business Solutions 45 Immunicon dependence 45 hydrophobic docetaxel prodrug nanoparticle 45 Oxyview Cannula 45 encompass SkyWest 45 About NuVasive NuVasive 45 impactof 45 Completes Restructuring 45 rxRNA 45 proprietary biomaterials 45 containing LABAs 45 Stanza Systems 45 sells Osteocel R 45 genericization 45 Efient 45 cancellations rescheduling 45 anddistribution 45 Enjuvia 45 Eriez manufactures 45 TGF Beta Shield 45 objectives anticipations 45 StratoComm Corporation 45 PHRM 45 Innovate Oncology 45 reflect Ronn Motors 45 without limitation Terremark 45 #.#-# mln eur [001] 45 contain Senomyx flavor 45 tolevamer 45 ENRICH trial 45 involve risksand uncertainties 45 midstage clinical 45 SynCon ™ 45 Ms. Falberg 45 BPE Segment 45 bioseparation 45 product commercializations 45 Oxytrex 45 SmartChip TM product 45 Medtronic Novartis 45 therapeutic peptide 45 whitepaper outlines 45 Sycrest 45 Enter MasterCard inControl 45 Filtran Microcircuits Inc. 45 acquisitions divestitures strategic alliances 45 drilling recompletions 45 Stragen 45 CHDI Foundation 45 ePort devices 45 NDA resubmission 45 CSL GlaxoSmithKline Plc 45 Alzhemed TM 45 inhaled insulin Exubera 45 ZIPI 45 Technosphere Insulin System 45 im peramivir 45 VaxGen stockholders 45 Onko Sure IVD 45 ONTAK 45 patented Bioral R nanocochleate 45 President Walter Merschat 45 muscarinic receptor agonists 45 Lexaria routinely evaluates 44 Bagger Dave concept 44 visit www.jbhunt.com 44 file INDs 44 Wayne Badovinus president 44 R alvimopan 44 CholeraGarde R Peru 44 DGAT1 inhibitors 44 Hopper costarred 44 antimicrobial biomaterials 44 Nasdaq UNIS 44 approved zileuton CR 44 SANDS ® 44 inAsia Pacific 44 Specialty Injectable Pharmaceuticals 44 OncoVex 44 IGXT IntelGenx today 44 PRECISE Trial 44 BIOGAS NORD 44 commercializes VIVITROL ® 44 EP #R 44 proprietary albumin fusion 44 AMEVIVE 44 CPTR 44 AIR Insulin 44 Avivo Corporation 44 Hemopurifier ® 44 LNP formulations 44 Boosts Guidance 44 affect Petroflow 44 muscarinic receptor agonist 44 superior bioprocessing 44 Benou added 44 topical dermatological products 44 GE Healthcare Philips 44 commercialize Hematide 44 involverisks 44 Will.i.am collaborated 44 Bioral Amphotericin B 44 manufacture PolyHeme 44 Anturol TM 44 vinorelbine tartrate 44 topical emulsion 44 topical hemostat 44 internet website www.mcmoran.com 44 forodesine hydrochloride BCX 44 Envirosell monitors 44 Phase IIb clinical trials 44 Exent delivers 44 Ceragenin ™ 44 FierceGovernmentIT tracks 44 SurModics Bravo 44 BrachySil TM 44 GlaxoSmithKline Sanofi Aventis 44 Angiox ® 44 Encysive Pharmaceuticals Nasdaq ENCY 44 balsalazide tablet 44 economicconditions 44 Airvana anticipates 44 Lipsovir ® 44 molecular imaging radiopharmaceuticals 44 HDL Selective Delipidation 44 polymer platinate 44 Emezine R 44 Targretin capsules 44 Anadis Limited 44 commercialize Aganocides 44 Direvo Biotech 44 forodesine 44 intents beliefs 44 XSEL beliefs 44 ophthalmologists optometrists universities 44 TransVax 44 potentially treat nephropathic 44 SAPIEN XT 44 AIDS prophylaxis congestive 44 contingent guaranties 44 Activision Publishing maintains 44 visit www.tpna.com 44 executional excellence 44 Daytrana ™ 44 Lupuzor 44 Kirin Pharma 44 itsproducts 44 Julie Inskeep 44 IGN# 44 cervical breast 44 CTTV Investments 44 TEAM TSAT 44 IMC #B 44 NYSE Amex NBS NeoStem 44 staphylococcal vaccine 44 affecting Amarin 44 Dr. Gamzu 44 Bioral 44 Pending regulatory approvals 44 UPDAT 44 diazepam rectal gel 44 AMPS Hedging Committee 44 screenprint channel 44 undertakes noobligation 44 Inc. http:/www.QuigleyPharma.com conducts 44 commercialization 44 PLAVIX R patent 44 lymphoma multiple sclerosis 44 forodesine HCl 44 Aptuit Informatics 44 NumeriTrack